Target Treatment with StrataDx's
- Employer
- Strata
- Location
- United States
- Closing date
- Jan 31, 2019
View more
- Profession
- Physician
- Specialty
- Dermatology
Target Treatment with StrataDx's Onychodystrophy DNA Test
The answers you need to guide your nail infection treatment
Targeted Technology Knowing the genus/species of the causative agent allows for targeted therapy. 99.9% Analytical Specificity
Accurate Correlates highly with gold standard histology, while providing identification of genus/species. 86% Clinical Sensitivity
Timely Rapid results mean the right treatment, right away 48-72 hrs. Turnaround Time
Cost-Effective Quick identification of genus/species supports informed treatment decisions that can more quickly lead to effective outcomes. Effective Outcomes
Required Many payors require precise identification of fungal species for preauthorization of anti-fungal Rx.
Payor Required Covered StrataDx's onychodystrophy DNA test is covered by Medicare and most insurance plans Payer
Learn more: StrataDx.com Call Now: 800-325-PATH (7284)
Get job alerts
Create a job alert and receive personalized job recommendations straight to your inbox.
Create alert